HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitochondrial protein ATPase family, AAA domain containing 3A correlates with radioresistance in glioblastoma.

AbstractBACKGROUND:
ATPase-family, AAA domain containing 3A (ATAD3A) is located on human chromosome 1p36.33, and high endogenous expression may associate with radio- and chemosensitivity. This study was conducted to investigate the significance of ATAD3A in glioblastoma multiforme (GBM).
METHODS:
Clinical significance of ATAD3A expression was assessed by immunohistochemistry in 67 GBM specimens, and prognostic value was assessed in 32 GBM patients statistically. To investigate in vitro phenotypic effects of ATAD3A, cell viability was measured using a clonogenic survival assay under either knockdown or ectopic expression of ATAD3A in GBM cell lines. The effects of ATAD3A knockdown on targeted DNA repair-associated proteins in T98G cells were evaluated using immunofluorescence and Western blotting.
RESULTS:
Clinically, high expression of ATAD3A was independent of O(6)-DNA methylguanine-methyltransferase methylation status and correlated with worse prognosis. In vitro, high ATAD3A-expressing T98G cells were more resistant to radiation-induced cell death compared with control and low endogenous ATAD3A U87MG cells. After silencing ATAD3A, T98G cells became more sensitive to radiation. On the other hand, enforced ATAD3A expression in U87MG cells exhibited increased radioresistance. ATAD3A may coordinate with aldo-keto reductase genes and participate in bioactivation or detoxication of temozolomide. Surprisingly, deficient DNA repair after irradiation was observed in T98G/ATAD3A knockdown as a result of decreased nuclear ataxia telangiectasia mutated kinase and histones H2AX and H3, which was also evidenced by the sustained elevation of poly (ADP-ribose) polymerase prior to and after radiation treatment.
CONCLUSION:
Our data suggest that high expression of ATAD3A is an independent biomarker for radioresistance in GBM. ATAD3A could be a potential target for therapy.
AuthorsWeir-Chiang You, Shiow-Her Chiou, Chih-Yang Huang, Shu-Fen Chiang, Cheng-Lin Yang, Janaki N Sudhakar, Tze-Yi Lin, I-Ping Chiang, Chiung-Chyi Shen, Wen-Yu Cheng, Jin-Chin Lin, Shwn-Huey Shieh, Kuan-Chih Chow
JournalNeuro-oncology (Neuro Oncol) Vol. 15 Issue 10 Pg. 1342-52 (Oct 2013) ISSN: 1523-5866 [Electronic] England
PMID24057885 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ATAD3A protein, human
  • Antineoplastic Agents, Alkylating
  • Membrane Proteins
  • Mitochondrial Proteins
  • RNA, Messenger
  • RNA, Small Interfering
  • Dacarbazine
  • O(6)-Methylguanine-DNA Methyltransferase
  • Adenosine Triphosphatases
  • ATPases Associated with Diverse Cellular Activities
  • Temozolomide
Topics
  • ATPases Associated with Diverse Cellular Activities
  • Adenosine Triphosphatases (antagonists & inhibitors, genetics, metabolism)
  • Antineoplastic Agents, Alkylating (therapeutic use)
  • Blotting, Western
  • Brain Neoplasms (metabolism, pathology, radiotherapy)
  • Cell Differentiation
  • Cell Proliferation
  • Chemoradiotherapy
  • DNA Methylation
  • Dacarbazine (analogs & derivatives, therapeutic use)
  • Female
  • Gene Expression Regulation, Neoplastic (radiation effects)
  • Glioblastoma (metabolism, pathology, radiotherapy)
  • Humans
  • Immunoenzyme Techniques
  • Male
  • Membrane Proteins (antagonists & inhibitors, genetics, metabolism)
  • Middle Aged
  • Mitochondria (metabolism)
  • Mitochondrial Proteins (antagonists & inhibitors, genetics, metabolism)
  • Neoplasm Staging
  • O(6)-Methylguanine-DNA Methyltransferase (genetics, metabolism)
  • Prognosis
  • RNA, Messenger (genetics)
  • RNA, Small Interfering (genetics)
  • Radiation Tolerance
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Survival Rate
  • Temozolomide
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: